Reprogramming the Epigenome With Vitamin C

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2019 Aug 6

PMID 31380368

Citations 68

Authors

Taylor Lee Chong

Emily L Ahearn

Luisa Cimmino

Affiliations

Soon will be listed here.

Abstract

The erasure of epigenetic modifications across the genome of somatic cells is an essential requirement during their reprogramming into induced pluripotent stem cells (iPSCs). Vitamin C plays a pivotal role in remodeling the epigenome by enhancing the activity of Jumonji-C domain-containing histone demethylases (JHDMs) and the ten-eleven translocation (TET) proteins. By maintaining differentiation plasticity in culture, vitamin C also improves the quality of tissue specific stem cells derived from iPSCs that are highly sought after for use in regenerative medicine. The ability of vitamin C to potentiate the activity of histone and DNA demethylating enzymes also has clinical application in the treatment of cancer. Vitamin C deficiency has been widely reported in cancer patients and has recently been shown to accelerate cancer progression in disease models. Therapies involving high-dose vitamin C administration are currently gaining traction in the treatment of epigenetic dysregulation, by targeting aberrant histone and DNA methylation patterns associated with cancer progression.

Citing Articles

Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential.

Alberts A, Moldoveanu E, Niculescu A, Grumezescu A Molecules. 2025; 30(3).

PMID: 39942850 PMC: 11820684. DOI: 10.3390/molecules30030748.

Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective.

Sanduzzi Zamparelli S, Sanduzzi Zamparelli A, Bocchino M Life (Basel). 2025; 15(1).

PMID: 39860053 PMC: 11766556. DOI: 10.3390/life15010113.

Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome.

Gunapala K, Gadban A, Noreen F, Schar P, Benvenisty N, Taylor V Int J Mol Sci. 2024; 25(23).

PMID: 39684429 PMC: 11641479. DOI: 10.3390/ijms252312718.

Advancing skin model development: A focus on a self-assembled, induced pluripotent stem cell-derived, xeno-free approach.

Dubau M, Tripetchr T, Mahmoud L, Kral V, Kleuser B J Tissue Eng. 2024; 15:20417314241291848.

PMID: 39502328 PMC: 11536386. DOI: 10.1177/20417314241291848.

Vitamin C in the Management of Thyroid Cancer: A Highway to New Treatment?.

Gorini F, Tonacci A Antioxidants (Basel). 2024; 13(10).

PMID: 39456495 PMC: 11505632. DOI: 10.3390/antiox13101242.

References

Semenza G . Perspectives on oxygen sensing. Cell. 1999; 98(3):281-4. DOI: 10.1016/s0092-8674(00)81957-1. View

Padayatty S, Levine M . New insights into the physiology and pharmacology of vitamin C. CMAJ. 2001; 164(3):353-5. PMC: 80729. View

Macdonald L, Thumser A, Sharp P . Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br J Nutr. 2002; 87(2):97-100. DOI: 10.1079/BJN2001492. View

Lando D, Peet D, Gorman J, Whelan D, Whitelaw M, Bruick R . FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002; 16(12):1466-71. PMC: 186346. DOI: 10.1101/gad.991402. View

Garnis C, Buys T, Lam W . Genetic alteration and gene expression modulation during cancer progression. Mol Cancer. 2004; 3:9. PMC: 408463. DOI: 10.1186/1476-4598-3-9. View

Padayatty S, Sun H, Wang Y, Riordan H, Hewitt S, Katz A . Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004; 140(7):533-7. DOI: 10.7326/0003-4819-140-7-200404060-00010. View

Krishnamurthy J, Torrice C, Ramsey M, Kovalev G, Al-Regaiey K, Su L . Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004; 114(9):1299-307. PMC: 524230. DOI: 10.1172/JCI22475. View

Mayland C, Bennett M, Allan K . Vitamin C deficiency in cancer patients. Palliat Med. 2005; 19(1):17-20. DOI: 10.1191/0269216305pm970oa. View

Hackanson B, Robbel C, Wijermans P, Lubbert M . In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. Ann Hematol. 2005; 84 Suppl 1:32-8. DOI: 10.1007/s00277-005-0004-1. View

10.

Tsukada Y, Fang J, Erdjument-Bromage H, Warren M, Borchers C, Tempst P . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2005; 439(7078):811-6. DOI: 10.1038/nature04433. View

11.

Clifton I, McDonough M, Ehrismann D, Kershaw N, Granatino N, Schofield C . Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins. J Inorg Biochem. 2006; 100(4):644-69. DOI: 10.1016/j.jinorgbio.2006.01.024. View

12.

Savitt J, Dawson V, Dawson T . Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006; 116(7):1744-54. PMC: 1483178. DOI: 10.1172/JCI29178. View

13.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

14.

Klose R, Kallin E, Zhang Y . JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006; 7(9):715-27. DOI: 10.1038/nrg1945. View

15.

Shadduck R, Latsko J, Rossetti J, Haq B, Abdulhaq H . Recent advances in myelodysplastic syndromes. Exp Hematol. 2007; 35(4 Suppl 1):137-43. DOI: 10.1016/j.exphem.2007.01.022. View

16.

Keith B, Simon M . Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129(3):465-72. PMC: 3150586. DOI: 10.1016/j.cell.2007.04.019. View

17.

Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane J, Tian S . Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858):1917-20. DOI: 10.1126/science.1151526. View

18.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

19.

Murry C, Keller G . Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008; 132(4):661-80. DOI: 10.1016/j.cell.2008.02.008. View

20.

Wernig M, Zhao J, Pruszak J, Hedlund E, Fu D, Soldner F . Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008; 105(15):5856-61. PMC: 2311361. DOI: 10.1073/pnas.0801677105. View